EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Biology, Geography & Health: Chapter 11138


Chapter 11138 provides bibliographic information on scholary research in the basic and applied life, earth and health sciences.





Kropp, J.; Eisenhut, M.; Ambrose, K.R.; Knapp, F.F.; Franke, W.G., 1999:
Pharmacokinetics and metabolism of the methyl-branched fatty acid (BMIPP) in animals and humans

Kestell, P.; Pruijn, F., B.; Siim, B., G.; Palmer, B., D.; Wilson, W., R., 2000:
Pharmacokinetics and metabolism of the nitrogen mustard bioreductive drug 5-(N,N-bis(2-chloroethyl)amino)-2,4-dinitrobenzamide (SN 23862) and the corresponding aziridine (CB 1954) in KHT tumour-bearing mice

Washio, T.; Kohsaka, K.; Arisawa, H.; Masunaga, H., 2003:
Pharmacokinetics and metabolism of the novel muscarinic receptor agonist SNI-2011 in rats and dogs

Khalili, P.; Naimi, E.; Knaus, E.E.; Wiebe, L.I., 2002:
Pharmacokinetics and metabolism of the novel synthetic C-nucleoside, 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine

Trudeau-Lame, M.E.; Kalgutkar, A.S.; LaFontaine, M., 2003:
Pharmacokinetics and metabolism of the reactive oxygen scavenger alpha-phenyl-N-tert-butylnitrone in the male Sprague-Dawley rat


Szprengier Juszkiewicz, T.; Junkuszew, W.; Semeniuk, S., 1998:
Pharmacokinetics and milk residues of fenbendazole and metabolites in dairy cows

Perez, S.; Solans, C.; Bregante, M.A.; Pinilla, I.; García, M.A.; Honrubia, F., 2002:
Pharmacokinetics and ocular penetration of grepafloxacin in albino and pigmented rabbits

Liu, X-Wen.; Song, H-Feng.; Tang, Z-Ming.; Zhao, K.; Zhu, B-Zhen.; Wang, L-Ping.; Zhang, Y., 2002:
Pharmacokinetics and partial thromboplastin time after intravenous recombinant hirudin variant-2 in rhesus monkeys

Song, H.F.; Liu, X.W.; Tang, Z.M., 1999:
Pharmacokinetics and peripheral platelet counts after a single dose of recombinant human thrombopoietin in rhesus monkeys

Harder, S.; Kirchmaier, C.M.; Krzywanek, H.J.; Westrup, D.; Bae, J.W.; Breddin, H.K., 1999:
Pharmacokinetics and pharmacodynamic effects of a new antibody glycoprotein IIb/IIIa inhibitor (YM337) in healthy subjects

Fishbein, L.; O'Brien, P.; Hutson, A.; Theriaque, D.; Stacpoole, P.W.; Flotte, T., 2000:
Pharmacokinetics and pharmacodynamic effects of nicotine nasal spray devices on cardiovascular and pulmonary function

Lugo, S.I.; Liang, Z.; Eddington, N.D., 1998:
Pharmacokinetics and pharmacodynamic of mivacurium stereoisomers in beagle dogs using twitch height and train-of-four response

Wang-Guang-Ji; Gao-Ling; Yang-Ping; Sun-Jian-Guo; Fu-Ji-Hua; Zhang-Zi-Qiang, 2000:
Pharmacokinetics and pharmacodynamics of 7-(4-chlorbenzyl)-7,8,13,13 a-tetrahydroberberine chloride in dogs

Kageyama, S.; Yamamoto, H.; Nakazawa, H.; Matsushita, J.; Kouyama, T.; Gonsho, A.; Ikeda, Y.; Yoshimoto, R., 2002:
Pharmacokinetics and pharmacodynamics of AJW200, a humanized monoclonal antibody to von Willebrand factor, in monkeys

Lahlou, N.; Carel, J.C.; Chaussain, J.L.; Roger, M., 2000:
Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics

Napolitano, A.; Del Dotto, P.; Petrozzi, L.; Dell'Agnello, G.; Bellini, G.; Gambaccini, G.; Bonuccelli, U., 1999:
Pharmacokinetics and pharmacodynamics of L-Dopa after acute and 6-week tolcapone administration in patients with Parkinson's disease

Zia-Amirhosseini, P.; Minthorn, E.; Benincosa, L.J.; Hart, T.K.; Hottenstein, C.S.; Tobia, L.A.; Davis, C.B., 1999:
Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeys

Fujita, T.; Matsumoto, Y.; Kimura, T.; Yokota, S.; Sawada, M.; Majima, M.; Ohtani, Y.; Kumagai, Y., 2002:
Pharmacokinetics and pharmacodynamics of TF-505, a novel nonsteroidal 5alpha-reductase inhibitor, in normal subjects treated with single or multiple doses

Benincosa, L.J.; Chow, F.S.; Tobia, L.P.; Kwok, D.C.; Davis, C.B.; Jusko, W.J., 2000:
Pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody to factor IX in cynomolgus monkeys

Abad-Santos, F.; Gálvez-Múgica, M.Angeles.; Santos, M.Angeles.; Novalbos, Jús.; Gallego-Sandín, S.; Méndez, P.; Casimiro, C.; Gilsanz, F., 2003:
Pharmacokinetics and pharmacodynamics of a single bolus of propofol 2% in healthy volunteers

Bantar, C.; Nicola, F.; Arenoso, H.J.; Galas, M.; Soria, L.; Dana, D.; Rossi, A.; Bianchini, H.; Jasovich, A., 1999:
Pharmacokinetics and pharmacodynamics of amoxicillin-sulbactam, a novel aminopenicillin-beta-lactamase inhibitor combination, against Escherichia coli

Yu, R.Z.; Zhang, H.; Geary, R.S.; Graham, M.; Masarjian, L.; Lemonidis, K.; Crooke, R.; Dean, N.M.; Levin, A.A., 2001:
Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in mice

Sharma, A.; Jusko, W.J.; Fulmor, I.E.; Norton, J.; Uderman, H.D.; Salazar, D.E., 1999:
Pharmacokinetics and pharmacodynamics of avitriptan during intravenous administration in healthy subjects

Marshall, J.D.; Wells, T.G.; Letzig, L.; Kearns, G.L., 1998:
Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients

Tam, V.H.; McKinnon, P.S.; Akins, R.L.; Drusano, G.L.; Rybak, M.J., 2003:
Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function

Zeamari, S.; Floot, B.; van der Vange, N.; Stewart, F.A., 2003:
Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC)

Hochhaus, G.; Barth, J.; al-Fayoumi, S.; Suarez, S.; Derendorf, H.; Hochhaus, R.; Möllmann, H., 2001:
Pharmacokinetics and pharmacodynamics of dexamethasone sodium-m-sulfobenzoate (DS) after intravenous and intramuscular administration: a comparison with dexamethasone phosphate (DP)

Shangraw, R.E.; Fisher, D.M., 1999:
Pharmacokinetics and pharmacodynamics of dichloroacetate in patients with cirrhosis

Han Zhenhua; Niu Xiaolin, 1999:
Pharmacokinetics and pharmacodynamics of dl-telraydropalmatine in rabbits

Wise, R.; Honeybourne, D., 1999:
Pharmacokinetics and pharmacodynamics of fluoroquinolones in the respiratory tract

Trampuz, A.; Laifer, G.; Wenk, M.; Rajacic, Z.; Zimmerli, W., 2002:
Pharmacokinetics and pharmacodynamics of gatifloxacin against Streptococcus pneumoniae and Staphylococcus aureus in a granulocyte-rich exudate

Kowari, K.; Hirosawa, I.; Kurai, H.; Utoguchi, N.; Fujii, M.; Watanabe, Y., 2002:
Pharmacokinetics and pharmacodynamics of human chorionic gonadotropin (hCG) after rectal administration of hollow-type suppositories containing hCG

Burger, D.; Boyd, M.; Duncombe, C.; Felderhof, M.; Mahanontharit, A.; Ruxrungtham, K.; Ubolyam, S.; Stek, M.; Cooper, D.; Lange, J.; Phanupak, P.; Reiss, P., 2003:
Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients

Dershwitz, M.; Walsh, J.L.; Morishige, R.J.; Connors, P.M.; Rubsamen, R.M.; Shafer, S.L.; Rosow, C.E., 2000:
Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers

Wermeling, D.; Drass, M.; Ellis, D.; Mayo, M.; McGuire, D.; O'Connell, D.; Hale, V.; Chao, S., 2003:
Pharmacokinetics and pharmacodynamics of intrathecal ziconotide in chronic pain patients

Kim, E.J.; Lee, A.K.; Kim, S.H.; Kim, S.G.; Lee, M.G., 2003:
Pharmacokinetics and pharmacodynamics of intravenous azosemide in mutant Nagase analbuminemic rats

Svetyi, L.I.; Alekhin, S.N., 2002:
Pharmacokinetics and pharmacodynamics of isradipine in patients with arterial hypertension

Nordt, T., K.; Moser, M.; Kohler, B.; Kuebler, W.; Bode, C., 1999:
Pharmacokinetics and pharmacodynamics of lanoteplase (n-PA)

Trampuz, A.; Wenk, M.; Rajacic, Z.; Zimmerli, W., 2000:
Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid

Eriksson, H.; Eriksson, U.G.; Frison, L.; Hansson, P.O.; Held, P.; Holmström, M.; Hägg, A.; Jonsson, T.; Lapidus, L.; Leijd, B.; Stockelberg, D.; Säfwenberg, U.; Taghavi, A.; Thorsén, M., 1999:
Pharmacokinetics and pharmacodynamics of melagatran, a novel synthetic LMW thrombin inhibitor, in patients with acute DVT

Roberts, M.S.; Wu, Z.Y.; Siebert, G.A.; Anissimov, Y.G.; Thompson, J.F.; Smithers, B.M., 2001:
Pharmacokinetics and pharmacodynamics of melphalan in isolated limb infusion for recurrent localized limb malignancy

Gatti, G.; Castelli-Gattinara, G.; Cruciani, M.; Bernardi, S.; D.P.scalis, C.R.; Pontali, E.; Papa, L.; Miletich, F.; Bassetti, D., 2003:
Pharmacokinetics and pharmacodynamics of nelfinavir administered twice or thrice daily to human immunodeficiency virus type 1-infected children

Blumer, J.L., 1998:
Pharmacokinetics and pharmacodynamics of new and old antimicrobial agents for acute otitis media

Eliot, L.A.; Jamali, F., 1999:
Pharmacokinetics and pharmacodynamics of nifedipine in untreated and atorvastatin-treated hyperlipidemic rats

Balis, F.M.; Holcenberg, J.S.; Poplack, D.G.; Ge, J.; Sather, H.N.; Murphy, R.F.; Ames, M.M.; Waskerwitz, M.J.; Tubergen, D.G.; Zimm, S.; Gilchrist, G.S.; Bleyer, W.A., 1998:
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study

Duvaldestin, P.; Slavov, V.; Rebufat, Y., 1999:
Pharmacokinetics and pharmacodynamics of rapacuronium in patients with cirrhosis

Bush, M.A.; Samara, E.; Whitehouse, M.J.; Yoshizawa, C.; Novicki, D.L.; Pike, M.; Laham, R.J.; Simons, M.; Chronos, N.A., 2001:
Pharmacokinetics and pharmacodynamics of recombinant FGF-2 in a phase I trial in coronary artery disease

Kato, M.; Okano, K.; Sakamoto, Y.; Miura, K.; Uchimura, T.; Saito, K., 2001:
Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in rats

Wulf, H.; Worthmann, F.; Behnke, H.; Böhle, A.S., 1999:
Pharmacokinetics and pharmacodynamics of ropivacaine 2 mg/mL, 5 mg/mL, or 7.5 mg/mL after ilioinguinal blockade for inguinal hernia repair in adults

Matsumoto, Y.; Ishiko, O.; Nakagawa, E.; Sumi, T.; Hyun, Y.; Ando, Y.; Ogita, S., 2001:
Pharmacokinetics and pharmacodynamics of serum platinum of gynecologic cancer patients treated with nedaplatin

Reimann, J.D.; Modi, N.B.; Novotny, W., 2000:
Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered GP IIb/IIIa antagonist, following coadministration of aspirin and heparin

Modi, N.B.; Novotny, W.; Reimann, J.D.; Cannon, C.P.; Braunwauld, E., 1999:
Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered IIb/IIIa antagonist, in patients with acute coronary syndrome

Lepore, M.; Pampanelli, S.; Fanelli, C.; Porcellati, F.; Bartocci, L.; D.V.ncenzo, A.; Cordoni, C.; Costa, E.; Brunetti, P.; Bolli, G.B., 2000:
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro

Modi, N.B.; Fox, N.L.; Clow, F.W.; Tanswell, P.; Cannon, C.P.; Van de Werf, F.; Braunwald, E., 2000:
Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction

Aweeka, F.; Trapnell, C.; Chernoff, M.; Jayewardene, A.; Spritzler, J.; Bellibas, S.E.alp; Lizak, P.; Jacobson, J., 2001:
Pharmacokinetics and pharmacodynamics of thalidomide in HIV patients treated for oral aphthous ulcers: ACTG Protocol 251

Dingemanse, J.; Halabi, A.; Kleinbloesem, C.H.; Heinig, R.; Blume, H., 1999:
Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor metrifonate in patients with renal impairment

Schywalsky, M.; Ihmsen, H.; Tzabazis, A.; Fechner, J.; Burak, E.; Vornov, J.; Schwilden, H., 2003:
Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rats

Soriano, S.G.; Sullivan, L.J.; Venkatakrishnan, K.; Greenblatt, D.J.; Martyn, J.A., 2001:
Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy

Blobner, M.; Kochs, E.; Fink, H.; Mayer, B.; Veihelmann, A.; Brill, T.; Stadler, J., 1999:
Pharmacokinetics and pharmacodynamics of vecuronium in rats with systemic inflammatory response syndrome: treatment with NG-monomethyl-L-arginine

Marzo, A.; Dal Bo, L.; Mazzucchelli, P.; Monti, N.C.; Tettamanti, R.A.; Crivelli, F.; Uhr, M.R.; Ismaili, S.; Giusti, A., 2000:
Pharmacokinetics and pharmacodynamics of zofenopril in healthy volunteers

Chen, T.; Berenson, J.; Vescio, R.; Swift, R.; Gilchick, A.; Goodin, S.; LoRusso, P.; Ma, P.; Ravera, C.; Deckert, F.; Schran, H.; Seaman, J.; Skerjanec, A., 2002:
Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases

Schiere, S.; Proost, J.H.; Schuringa, M.; Wierda, J.M., 1999:
Pharmacokinetics and pharmacokinetic-dynamic relationship between rapacuronium (Org 9487) and its 3-desacetyl metabolite (Org 9488)

Shipkova, M.; Armstrong, V.W.; Weber, L.; Niedmann, P.D.; Wieland, E.; Haley, J.; Tönshoff, B.; Oellerich, M., 2002:
Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients

Ensom, M.H.H.; Partovi, N.; Decarie, D.; Dumont, R.J.; Fradet, G.; Levy, R.D., 2002:
Pharmacokinetics and protein binding of mycophenolic acid in stable lung transplant recipients

Vuylsteke, A.; Milner, Q.; Ericsson, H.; Mur, D.; Dunning, J.; Jolin-Mellgård, A.; Nordlander, M.; Latimer, R., 2000:
Pharmacokinetics and pulmonary extraction of clevidipine, a new vasodilating ultrashort-acting dihydropyridine, during cardiopulmonary bypass

DeGrado, T.R.; Reiman, R.E.; Price, D.T.; Wang, S.; Coleman, R.Edward., 2002:
Pharmacokinetics and radiation dosimetry of 18F-fluorocholine

Tromm, A.; Möllmann, H.; Barth, J.; Hochhaus, G.; Krieg, M.; Bigalke, C.; Möllmann, A.; Derendorf, H., 2001:
Pharmacokinetics and rectal bioavailability of hydrocortisone acetate after single and multiple administration in healthy subjects and patients

Deng Shu Hai; Huang Gui Hua; Zhang Na; M.F.ng Hua; Y.X.ao Tang; Deng Wen Hua, 1999:
Pharmacokinetics and relative bioavailability of azithromycin dispersing tablets in healthy volunteers

Jiang-Wei; Liang-Derong; Liang-Maozhi; Xu-Lan; Huang-Ying; Miao-Jia; Qing-Yongping; Yu-Qing; Zou-Yuangao, 1999:
Pharmacokinetics and relative bioavailability of domestic rufloxacin in Chinese healthy volunteers

Dai Yong Jian; W.Q.ong Zhu; Zheng Xu; Wang Fang, 1999:
Pharmacokinetics and relative bioavailability of isosorbide 5-mononitrate sustained release tablets

Dai Yong Jian; W.Q.ong Zhu; Wang Fang; Ding Li, 2000:
Pharmacokinetics and relative bioavailability of isosorbide dinitrate aerosol

M.X.aoya; Wang Meina; Wang Xinlong, 2001:
Pharmacokinetics and relative bioavailability of roxithromycin dispersive tablets in healthy volunteers

Du, X-Li.; Zhu, Z.; Fu, Q.; Li, D-Kui.; Xu, W-Bing., 2002:
Pharmacokinetics and relative bioavailability of salbutamol metered-dose inhaler in healthy volunteers

Wolf, D.L.; Rodríguez, C.A.; Mucci, M.; Ingrosso, A.; Duncan, B.A.; Nickens, D.J., 2003:
Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis

Trejtnar, F.; Laznicek, M.; Laznickova, A.; Mather, S.J., 2000:
Pharmacokinetics and renal handling of 99mTc-labeled peptides

Pellegrin, I.; Breilh, D.; Birac, V.; Deneyrolles, M.; Mercié, P.; Trylesinski, A.; Neau, D.; Saux, M.C.; Fleury, H.J.; Pellegrin, J.L., 2001:
Pharmacokinetics and resistance mutations affect virologic response to ritonavir/saquinavir-containing regimens

Hendrix, C.W.; Flexner, C.; MacFarland, R.T.; Giandomenico, C.; Fuchs, E.J.; Redpath, E.; Bridger, G.; Henson, G.W., 2000:
Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers

Erhardtsen, E.; Nilsson, P.; Johannessen, M.; Thomsen, M.S., 2001:
Pharmacokinetics and safety of FFR-rFVIIa after single doses in healthy subjects

Macleod, C.M.; Schotzinger, R.J.; Vanhove, G.F.; Bachand, R.T., 1999:
Pharmacokinetics and safety of a once-daily clarithromycin formulation

Marbury, T.C.; Blum, R.A.; Rauch, Cémence.; Pinquier, J-Louis., 2002:
Pharmacokinetics and safety of a single oral dose of once-daily alfuzosin, 10 mg, in male subjects with mild to severe renal impairment

Sadler, B.M.; Piliero, P.J.; Preston, S.L.; Lloyd, P.P.; Lou, Y.; Stein, D.S., 2001:
Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers

Tanaka, M.; Kato, K.; Hakusui, H.; Murakami, Y.; Sato, K.; Ito, Y.; Kawamoto, K., 2000:
Pharmacokinetics and safety of ascending single doses of DZ-2640, a new oral carbapenem antibiotic, administered to healthy Japanese subjects

Kanerva, H.; Kilkku, O.; Helminen, A.; Rouru, J.; Scheinin, M.; Huupponen, R.; Klebovich, I.; Drabant, S.; Urtti, A., 1999:
Pharmacokinetics and safety of deramciclane during multiple oral dosing

Davies, B.E.; Kirchin, M.A.; Bensel, K.; Lorusso, V.; Davies, A.; Parker, J.R.; Lafrance, N.D., 2002:
Pharmacokinetics and safety of gadobenate dimeglumine (multihance) in subjects with impaired liver function

Zhao, Q.; Iyer, G.R.; Verhaeghe, T.; Truyen, L., 2002:
Pharmacokinetics and safety of galantamine in subjects with hepatic impairment and healthy volunteers

Piscitelli, S.C.; Spooner, K.; Baird, B.; Chow, A.T.; Fowler, C.L.; Williams, R.R.; Natarajan, J.; Masur, H.; Walker, R.E., 1999:
Pharmacokinetics and safety of high-dose and extended-interval regimens of levofloxacin in human immunodeficiency virus-infected patients

Lorusso, V.; Taroni, P.; Alvino, S.; Spinazzi, A., 2001:
Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis

Zannikos, P.N.; Jensen, B.K.; Boutouyrie, B.X.; Tripp, L.; Yongyi, L.; McGowan, T.; Waldman, S.A.; Greenberg, H.E., 2000:
Pharmacokinetics and safety of single intravenous infusions of the adenosine agonist, AMP 579, in patients with end-stage renal insufficiency

Brattström, C.; Säwe, J.; Jansson, B.; Lönnebo, A.; Nordin, J.; Zimmerman, J.J.; Burke, J.T.; Groth, C.G., 2000:
Pharmacokinetics and safety of single oral doses of sirolimus (rapamycin) in healthy male volunteers

Laktionov, P.P.; Bryksin, A.V.; Rykova, E.Y.; Amirchanov, N.V.; Vlassov, V.V., 1999:
Pharmacokinetics and stability of phosphodiester and phosphorothioate 3'end modified oligonucleotides in the blood in vivo: A comparative study

Fowler, S.J.; Lipworth, B.J., 2001:
Pharmacokinetics and systemic beta2-adrenoceptor-mediated responses to inhaled salbutamol

Cao-Yi-Jin; Zhang-Jing; Cao-Guo-Ying; Shi-Yao-Guo; Zhang-Ying-Yuan, 2002:
Pharmacokinetics and the relative bioavailability of clarithromycin tablets and capsules

Mar, W.; Kim, K.N.; Choi, E.W.; Fang, M.Z.; Kwak, H.I.; Kim, M.Y.; Son, J.W.; Shin, M.K.; Bae, M.O.; Lee, B.J.; Lee, H.J.; Byun, T.H.; Park, S.Y.; Chun, B.H.; Byun, J.H.; Ahn, G.H.; Lee, Y.J.; Cho, M.H., 2000:
Pharmacokinetics and tissue distribution of B-domain deleted recombinant human factor VIII (GC-gamma AHF) in rats

Hepburn, T.W.; Hart, T.K.; Horton, V.L.; Sellers, T.S.; Tobia, L.P.; Urbanski, J.J.; Shi, W.; Davis, C.B., 2001:
Pharmacokinetics and tissue distribution of SB-251353, a novel human CXC chemokine, after intravenous administration to mice

Nikolajeva, V.; Eze, D.; Petrina, Z.; Muiznieks, I., 2002:
Pharmacokinetics and tissue distribution of adenylate deaminase from Penicillium lanoso-viride in mice

Wang, S.; Mi, J-Bo.; Li, Y-Zong.; Chang, W-Bao.; Ci, Y-Xiang.; Zhao, M-Zheng.; Zhao, Y-Kun.; Zhu, L-Ya.; Xu, G., 2003:
Pharmacokinetics and tissue distribution of iv injection of polyphase liposome-encapsulated cisplatin (KM-1) in rats

Bruzzese, T.; Rimaroli, C.; Bonabello, A.; Mozzi, G.; Ajay, S.; Cooverj, N.D., 2000:
Pharmacokinetics and tissue distribution of rifametane, a new 3-azinomethyl-rifamycin derivative, in several animal species

McNulty, M.J.; Hutabarat, R.H.; Findlay, J.W.A.; Devereux, K.; Knick, V.C.; Harvey, R.J.; Molina, L., 2003:
Pharmacokinetics and tissue distribution of the nonadecapeptide Moli1901 in rats and mice

Gee, T.; Andrews, J.M.; Ashby, J.P.; Marshall, G.; Wise, R., 2001:
Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose

Gee, T.; Ellis, R.; Marshall, G.; Andrews, J.; Ashby, J.; Wise, R., 2001:
Pharmacokinetics and tissue penetration of linezolid following multiple oral doses

Gascón, A.R.; Gutiérrez-Aragón, G.; Hernández, R.M.; Errasti, J.; Pedraz, J.L., 2003:
Pharmacokinetics and tissue penetration of pefloxacin plus metronidazole after administration as surgical prophylaxis in colorectal surgery

Luzzati, R.; Sanna, A.; Allegranzi, B.; Nardi, S.; Berti, M.; Barisoni, D.; Concia, E., 2000:
Pharmacokinetics and tissue penetration of vancomycin in patients undergoing prosthetic mammary surgery

Levy, G., A.; Grant, D.; Paradis, K.; Campestrini, J.; Smith, T.; Kovarik, J., M., 2001:
Pharmacokinetics and tolerability of 40-0-(2-hydroxyethyl)rapamycin in de novo liver transplant recipients

Moore, K.H.; Cass, L.M.; Dallow, N.; Hardman, T.C.; Jones, A.; Boyce, M.; Prince, W.T., 2001:
Pharmacokinetics and tolerability of GW420867X, a nonnucleoside reverse transcriptase inhibitor, following single escalating doses in healthy male volunteers

Stockis, A.; D.B.uyn, S.; Gengler, C.; Goethals, F.; Lens, S.; Poli, G.; Acerbi, D., 2003:
Pharmacokinetics and tolerability of a new manidipine and delapril fixed oral combination in young and elderly subjects

Fleishaker, J.C.; Pearson, L.K.; Knuth, D.W.; Gomez-Mancilla, B.; Francom, S.F.; McIntosh, M.J.; Freestone, S.; Azie, N.E., 1999:
Pharmacokinetics and tolerability of a novel 5-HT1D agonist, PNU-142633F

Sandberg, J., A.; Parker, V., P.; Blanchard, K., S.; Sweedler, D.; Powell, J., A.; Kachensky, A.; Bellon, L.; Usman, N.; Rossing, T.; Borden, E.; Blatt, L., M., 2000:
Pharmacokinetics and tolerability of an antiangiogenic ribozyme (ANGIOZYMETM) in healthy volunteers

Allen, A.; Bygate, E.; Oliver, S.; Johnson, M.; Ward, C.; Cheon, A.J.; Choo, Y.S.; Kim, I.C., 2000:
Pharmacokinetics and tolerability of gemifloxacin (SB-265805) after administration of single oral doses to healthy volunteers

Gammaitoni, A.R.; Davis, M.W., 2002:
Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing

Picollo, R.; Brion, N.; Gualano, V.; Millérioux, L.; Marchetti, M.; Rosignoli, M.Teresa.; Dionisio, P., 2003:
Pharmacokinetics and tolerability of prulifloxacin after single oral administration

Stalker, D.J.; Jungbluth, G.L.; Hopkins, N.K.; Batts, D.H., 2003:
Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers

Velez, G.; Yuan, P.; Sung, C.; Tansey, G.; Reed, G.F.; Chan, C.C.; Nussenblatt, R.B.; Robinson, M.R., 2001:
Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma

Kobylińska, K.; Koralewski, P.; Sobik, B.; Gasiorek, M.; Kobylińska, M., 2001:
Pharmacokinetics and toxicity of oral (-)-(S)-bromofosfamide in lung cancer patients

Fielding, R.M.; Moon-McDermott, L.; Lewis, R.O.; Horner, M.J., 1999:
Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey

Koizumi, T.; Kubo, K.; Hanaoka, M.; Miyahara, T.; Kaneki, T.; Yamamoto, H.; Ge, R.L.; Fujimoto, K.; Kobayashi, T.; Sekiguchi, M., 1998:
Pharmacokinetics characteristics of the novel anticancer agent CPT-11 and its active metabolite in plasma and lung lymph fluid following intravenous administration to sheep

Wasan, K.M.; Kennedy, A.L.; Cassidy, S.M.; Ramaswamy, M.; Holtorf, L.; Chou, J.W.; Pritchard, P.H., 1998:
Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: single-dose studies

Kobylińska, K.; Kobylińska, M.; Sobik, B., 2001:
Pharmacokinetics of (-)-(S)-bromofosfamide after intravenous and oral administration in mice

Uchida, T.; Aoyama, K.; Mori, K.; Usui, T.; Watanabe, T.; Takariki, Y.L.; Ashahara, N.; Hirose, M.; Kimura, T.; Tateishi, M.; Higuchi, S., 1998:
Pharmacokinetics of (125I)-recombinant human interleukin-11: 1. Absorption, distribution and excretion after subcutaneous administration to male rats

Uchida, T.; Aoyama, K.; Mori, K.; Usui, T.; Watanabe, T.; Takariki, Y.; Asahara, N.; Hirose, M.; Kimura, T.; Tateishi, M.; Higuchi, S., 1998:
Pharmacokinetics of (125I)-recombinant human interleukin-11: 2. Placental transfer and excretion into milk after subcutaneous administration to rats

Mcdowell, J., A.; Chittick, G., E.; Ravitch, J., R.; Polk, R., E.; Kerkering, T., M.; Stein, D., S., 1999:
Pharmacokinetics of (14C)abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: A mass balance study

Coldham, N., G.; Sauer, M., J., 2000:
Pharmacokinetics of (14C)genistein in the rat: Gender-related differences, potential mechanisms of biological action, and implications for human health

Gronroos, T.; Eskola, O.; Lehtio, K.; Minn, H.; Marjamaki, P.; Bergman, J.; Haaparanta, M.; Forsback, S.; Solin, O., 2001:
Pharmacokinetics of (18F)FETNIM: A potential hypoxia marker for PET

Ala-Kokko, T.I.; Karinen, J.; Räihä, E.; Kiviluoma, K.; Alahuhta, S., 2002:
Pharmacokinetics of 0.75% ropivacaine and 0.5% bupivacaine after ilioinguinal-iliohypogastric nerve block in children

Brandi, L.; Egfjord, M.; Olgaard, K., 2002:
Pharmacokinetics of 1,25(OH)(2)D(3) and 1alpha(OH)D(3) in normal and uraemic men

Fukuda, H.; Honda, C.; Wadabayashi, N.; Kobayashi, T.; Yoshino, K.; Hiratsuka, J.; Takahashi, J.; Akaizawa, T.; Abe, Y.; Ichihashi, M.; Mishima, Y., 1999:
Pharmacokinetics of 10B-p-boronophenylalanine in tumours, skin and blood of melanoma patients: a study of boron neutron capture therapy for malignant melanoma

Kobayashi, H.; Kao, C.H.; Kreitman, R.J.; Le, N.; Kim, M.K.; Brechbiel, M.W.; Paik, C.H.; Pastan, I.; Carrasquillo, J.A., 2000:
Pharmacokinetics of 111In- and 125I-labeled antiTac single-chain Fv recombinant immunotoxin

Cho, J.Gol.; Kim, M-Kon.; Oh, E.Jung.; Yoon, E.Jeong.; Sohn, J.; Park, M.Kyu.; Park, G.Hong., 2002:
Pharmacokinetics of (111)In-labeled triplex-forming oligonucleotide targeting human N-myc gene

Tombach, B.; Bremer, C.; Reimer, P.; Schaefer, R.M.; Ebert, W.; Geens, V.; Heindel, W., 2000:
Pharmacokinetics of 1M gadobutrol in patients with chronic renal failure

Zamek-Gliszczynski, M.J.; Xiong, H.; Patel, N.J.; Turncliff, R.Z.; Pollack, G.M.; Brouwer, K.L.R., 2003:
Pharmacokinetics of 5 (and 6)-carboxy-2',7'-dichlorofluorescein and its diacetate promoiety in the liver

Suvisaari, J.; Moo-Young, A.; Juhakoski, A.; Elomaa, K.; Saleh, S., I.; Lahteenmaki, P., 1999:
Pharmacokinetics of 7alpha-methyl-19-nortestosterone (MENTTM) delivery using subdermal implants in healthy men

Zhong, D-Fang.; Li, K.; Xu, J-Hua.; Du, Y.; Zhang, Y-Fan., 2003:
Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats

Trejtnar, F.; Laznicek, M.; Laznickova, A., 1998:
Pharmacokinetics of 99mTc-DTPMP as compared to 99mTc-MDP in the rat

Yang Xian Le; Liu Zhi Zhi; Yokoyama, M., 2003:
Pharmacokinetics of Ciprofloxacinum in Chinese mitten-handed crab, Eriocheir sinensis

Koch, C.J.; Hahn, S.M.; Rockwell, K.,. Jr.;; Covey, J.M.; Mckenna, W.G.; Evans, S.M., 2001:
Pharmacokinetics of EF5 (2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in human patients: Implications for hypoxia measurements in vivo by 2-nitroimidazoles

Falcoz, C.; Jenkins, J.M.; Bye, C.; Hardman, T.C.; Kenney, K.B.; Studenberg, S.; Fuder, H.; Prince, W.T., 2002:
Pharmacokinetics of GW433908, a prodrug of amprenavir, in healthy male volunteers

Biber, A., 2003:
Pharmacokinetics of Ginkgo biloba extracts

Yeganeh, M.H.; Ramzan, I., 2002:
Pharmacokinetics of H2-antagonists during propofol or thiopentone anaesthesia in rats

Yang Ming; Yang Chunzheng; M.J.anguo, 2000:
Pharmacokinetics of Homoharringtonine and its significance in chemotherapy of acute leukemia

Huber, J., 1998:
Pharmacokinetics of Implanon(R): An integrated analysis

Tangphao, O.; Chalon, S.; Moreno, H.; Hoffman, B.B.; Blaschke, T.F., 1999:
Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia

Evans, A.M.; Faull, R.; Fornasini, G.; Lemanowicz, E.F.; Longo, A.; Pace, S.; Nation, R.L., 2000:
Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis

Mukai, H.; Sugimoto, T.; Ago, M.; Morino, A., 1999:
Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105

Mukai, H.; Watanabe, S.; Tsuchida, K.; Morino, A., 1999:
Pharmacokinetics of NS-49, a phenethylamine class alpha(1A)-adrenoceptor agonist, at therapeutic doses in several animal species and interspecies scaling of its pharmacokinetic parameters

Tserng, K-Yi.; Ingalls, S.T.; Boczko, E.M.; Spiro, T.P.; Li, X.; Majka, S.; Gerson, S.L.; Willson, J.K.; Hoppel, C.L., 2003:
Pharmacokinetics of O6-benzylguanine (NSC637037) and its metabolite, 8-oxo-O6-benzylguanine

Barennes, H.; Verdier, F.; Clavier, F.; Pussard, E., 1999:
Pharmacokinetics of Quinimax(R) suppositories in children with malaria: A preliminary study

Han, K.S.; Lee, M.G., 1999:
Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects

Fish, D.N.; Abraham, E., 1999:
Pharmacokinetics of a clarithromycin suspension administered via nasogastric tube to seriously ill patients

Abrams, L., S.; Skee, D., M.; Natarajan, J.; Wong, F., A.; Anderson, G., D., 2002:
Pharmacokinetics of a contraceptive patch (EvraTM/Ortho EvraTM) containing norelgestromin and ethinyloestradiol at four application sites

Poher, I.; Blanc, G., 1999:
Pharmacokinetics of a discontinuous absorption process of oxolinic acid in turbot, Scophthalmus maximus, after a single oral administration

Bradley, J.S.; Kearns, G.L.; Reed, M.D.; Capparelli, E.V.; Vincent, J., 2000:
Pharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin

Kielbasa, W.; Fung, H.L., 2000:
Pharmacokinetics of a model organic nitrite inhalant and its alcohol metabolite in rats

Yan Ling Di; Gong Z.H.i; Liu Yong Shao; Qin B.Y., 2003:
Pharmacokinetics of a naltrexone sustained release preparation in dog

Shin, H.C.ul; Shim, H.O.; Yu, S.R.ong; Kim, J.C.oon; Yang, S.D.n; Chung, M.K.o, 2000:
Pharmacokinetics of a new PEG-hemoglobin SB1 for single intravenous administration to rats

Sugimoto, T.; Furuta, S.; Kawamata, H.; Suzuki, M.; Sano, H.; Ito, T.; Hirabayashi, N.; Imamura, F.; Matsuki, Y., 1999:
Pharmacokinetics of a new histamine H2-receptor antagonist, Z-300, in rat and dog

Kozawa, O.; Uematsu, T.; Matsuno, H.; Niwa, M.; Kohno, K.; Kawato, A.; Takahashi, K.; Nagashima, S.; Kanamaru, M., 2001:
Pharmacokinetics of a new parenteral oligosaccharide antibiotic, SCH27899 (Ziracin), in healthy subjects

Kim, H.J.; Han, K.S.; Chung, Y.K.; Chang, M.S.; Lee, M.G., 1998:
Pharmacokinetics of a new proton pump inhibitor, YJA-20379-8, in rats with 48-hour water deprivation

Rolf, C.; Kemper, S.; Lemmnitz, G.; Eickenberg, U.; Nieschlag, E., 2002:
Pharmacokinetics of a new transdermal testosterone gel in gonadotrophin-suppressed normal men

Yabuki, M.; Kon-Ya, Y.; Kataoka, M.; Shimizudani, T.; Akao, K.; Ito, M.; Kanamaru, H.; Nakatsuka, I., 2003:
Pharmacokinetics of a novel N-methyl-D-aspartate receptor antagonist (SM-18400): identification of an N-acetylated metabolite and pre-clinical assessment of N-acetylation polymorphism

Sista, S.; Lai, J.Chi-Keung.; Eradiri, O.; Albert, K.S., 2003:
Pharmacokinetics of a novel diltiazem HCl extended-release tablet formulation for evening administration

Javanbakht, M.; Singh, A.B.; Mazer, N.A.; Beall, G.; Sinha-Hikim, I.; Shen, R.; Bhasin, S., 2000:
Pharmacokinetics of a novel testosterone matrix transdermal system in healthy, premenopausal women and women infected with the human immunodeficiency virus

Sullivan, J.T.; Woodruff, M.; Lettieri, J.; Agarwal, V.; Krol, G.J.; Leese, P.T.; Watson, S.; Heller, A.H., 1999:
Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12-8039), a new enantiomerically pure 8-methoxy quinolone

Nagashima, S.; Kozawa, O.; Otsuka, T.; Kohno, K.; Minamoto, M.; Yokokawa, M.; Kanamaru, M.; Uematsu, T., 2000:
Pharmacokinetics of a parenteral carbapenem, biapenem, in patients with end-stage renal disease and influence of haemodialysis

Rao, V.V.; Rambhau, D.; Rao, B.R.; Srinivasu, P., 1998:
Pharmacokinetics of a single dose of phenylpropanolamine following oral administration at two different times of the day

Wiersma, H.E.; van Boxtel, C.J.; Butter, J.J.; van Aalderen, W.M.C.; Omari, T.; Benninga, M.A., 2003:
Pharmacokinetics of a single oral dose of baclofen in pediatric patients with gastroesophageal reflux disease

Singh, A.B.; Norris, K.; Modi, N.; Sinha-Hikim, I.; Shen, R.; Davidson, T.; Bhasin, S., 2001:
Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men

Izzedine, H.; Launay-Vacher, V.; Aymard, G.; Legrand, M.; Deray, G., 2001:
Pharmacokinetics of abacavir in HIV-1-infected patients with impaired renal function

Choi, J.Shik.; Burm, J.Pil., 2002:
Pharmacokinetics of acebutolol and its main metabolite, diacetolol after oral administration of acebutolol in rabbits with carbon tetrachloride-induced hepatic failure

Liu Hui Chen; H.Y.Q.n; L.X.n Fang; Hou Yan Ning; Wang Jian; Wang H.J.n, 1999:
Pharmacokinetics of acemetacin sustained-release capsules in healthy subjects

Morris, E.C.; Rebello, P.; Thomson, K.J.; Peggs, K.S.; Kyriakou, C.; Goldstone, A.H.; Mackinnon, S.; Hale, G., 2003:
Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications

L.D.ze, F.; Debruyne, D.; Albessard, F.; Barre, L.; Defer, G.L., 2000:
Pharmacokinetics of all-trans retinoic acid, 13-cis retinoic acid, and fenretinide in plasma and brain of Rat

Romans, D.A.; Barua, A.B.; Olson, J.Allen., 2003:
Pharmacokinetics of all-trans retinoyl beta-glucuronide in rats following intraperitoneal and oral administration

Rostaing, L.; Chatelut, E.; Payen, J.L.; Izopet, J.; Thalamas, C.; Ton-That, H.; Pascal, J.P.; Durand, D.; Canal, P., 1998:
Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications

Song, H.; Griesgraber, G.W.; Wagner, C.R.; Zimmerman, C.L., 2002:
Pharmacokinetics of amino acid phosphoramidate monoesters of zidovudine in rats

Dalton, J.T.; Meyer, M.C.; Golub, A.L., 1999:
Pharmacokinetics of aminolevulinic acid after oral and intravenous administration in dogs

Nahata, M.C.; Vashi, V.I.; Swanson, R.N.; Messig, M.A.; Chung, M., 1999:
Pharmacokinetics of ampicillin and sulbactam in pediatric patients

Fätkenheuer, G.; Römer, K.; Kamps, R.; Salzberger, B.; Burger, D., 2001:
Pharmacokinetics of amprenavir and lopinavir in combination with nevirapine in highly pretreated HIV-infected patients

Hauptmann, J., 2002:
Pharmacokinetics of an emerging new class of anticoagulant/antithrombotic drugs. A review of small-molecule thrombin inhibitors

Lin, C.; Gupta, S.; Loebenberg, D.; Cayen, M.N., 2000:
Pharmacokinetics of an everninomicin (SCH 27899) in mice, rats, rabbits, and cynomolgus monkeys following intravenous administration

Fisher, D.M.; Kellett, N.; Lenhardt, R., 2003:
Pharmacokinetics of an implanted osmotic pump delivering sufentanil for the treatment of chronic pain

Gupta, S.K.; Sathyan, G., 1999:
Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin

Yuan, J.; Wang, P.Q.; Ge, S.R.; An, F.R.; Shi, A.G.; Chen, J.; Liang, J.Y., 2001:
Pharmacokinetics of anastrozole in Chinese male volunteers

Ogiso, T.; Uchiyama, K.; Suzuki, H.; Yoshimoro, M.; Tanino, T.; Iwakai, M.; Uno, S., 2000:
Pharmacokinetics of aniracetam and its metabolites in rat brain

Weinbren, M.J., 2001:
Pharmacokinetics of antibiotics in burns patients

Reid, J.; Marciniuk, D.; Peloquin, C.A.; Hoeppner, V., 2002:
Pharmacokinetics of antituberculosis medications delivered via percutaneous gastrojejunostomy tube

Ahmad, S.; Yang, L.H.; Ahsan, A.; Fu, K.; Iqbal, O.; Hoppensteadt, D.A.; Lewis, B.E.; Walenga, J.M.; Fareed, J., 2000:
Pharmacokinetics of argatroban in primates: evidence on endogenous uptake

Wang, X.M.; Yu, X.Y.; Lin, S.G., 1999:
Pharmacokinetics of atenolol enantiomers in 12 Chinese healthy men

Ngo, L.Y.; Yogev, R.; Dankner, W.M.; Hughes, W.T.; Burchett, S.; Xu, J.; Sadler, B.; Unadkat, J.D., 1999:
Pharmacokinetics of azithromycin administered alone and with atovaquone in human immunodeficiency virus-infected children

Ahlstrom, H.; Alvero, J.; Alvero, R.; Espos, R.; Fajutrao, L.; Herrera, J.; Kjellman, B.; Kubista, J.; Leviste, C.; Meyer, P.; Oldaeus, G.; Siricururat, A.; Vichyanond, P.; Wettrell, G.; Wong, E.; Laxmyr, L.; Nyberg, L.; Olsson, H.; Weibull, E.; Rosenborg, J., 2002:
Pharmacokinetics of bambuterol during oral administration to asthmatic children

Na-Bangchang, K.; Karbwang, J.; Tasanor, U.; Thanavibul, A.; Farkad, E.; Mull, R., 1999:
Pharmacokinetics of benflumetol given as a fixed combination artemether-benflumetol (CGP 56697) in Thai patients with uncomplicated falciparum malaria

Hsu, J.Y.; Hsu, M.Y.; Hsu, H.C.u; Chen, S.J.ng; Wang, I.Pang, 1999:
Pharmacokinetics of benzbromarone in normal Chinese males

Martin, L.T.; Cretton-Scott, E.; Schinazi, R.F.; Zhou, X.J.; McClure, H.M.; Mathe, C.; Gosselin, G.; Imbach, J.L.; Sommadossi, J.P., 1999:
Pharmacokinetics of beta-L-2',3'-dideoxy-5-fluorocytidine in rhesus monkeys

Tan, X.; Boudinot, F.D.; Chu, C.K.; Egron, D.; Perigaud, C.; Gosselin, G.; Imbach, J.L., 2000:
Pharmacokinetics of bis(t-butyl-SATE)-AZTMP, a bispivaloylthioethyl prodrug for intracellular delivery of zidovudine monophosphate, in mice

Luurila, S.; Kautiainen, S.; Ylitalo, P.; Ylitalo, R., 1999:
Pharmacokinetics of bisphosphonates in rabbits

Jendbro, M.; Johansson, C.J.; Strandberg, P.; Falk-Nilsson, H.; Edsbäcker, S., 2001:
Pharmacokinetics of budesonide and its major ester metabolite after inhalation and intravenous administration of budesonide in the rat

Meunier, J.F.; Goujard, E.; Dubousset, A.M.; Samii, K.; Mazoit, J.X., 2001:
Pharmacokinetics of bupivacaine after continuous epidural infusion in infants with and without biliary atresia

Veering, B.Th.; Burm, A.G.L.; Feyen, H-Marieken.; Olieman, W.; M.S.uverijn, J.H.; Van Kleef, J.W., 2002:
Pharmacokinetics of bupivacaine during postoperative epidural infusion: enantioselectivity and role of protein binding

Sakr, A.; Andheria, M., 2001:
Pharmacokinetics of buspirone extended-release tablets: a single-dose study

Bonapace, C.R.; White, R.L.; Friedrich, L.V.; Norcross, E.D.; Bosso, J.A., 1999:
Pharmacokinetics of cefepime in patients with thermal burn injury

Loffreda, A.; Lampa, E.; Lucarelli, C.; Amorena, M.; Contaldi, C.; Calderaro, V.; Rossi, F., 1999:
Pharmacokinetics of cefodizime in patients with various degrees of renal failure

Chen-Jun; Jiang-Xue-Hua; Wang-Shuang-Mei, 2001:
Pharmacokinetics of cefoperazone administered alone and with tazobactam in dog

Datta, B.; Mandal, T.K.; Chakraborty, A.K., 2003:
Pharmacokinetics of cefotaxime in goats with experimentally induced kidney damage

Sun Gui Hua; Zhong W.Z.uang; Song Hong; Zhou Lan; L.Y.u Zhi, 2003:
Pharmacokinetics of cefuroxime, cefmetazole in dogs' bile

Paulson, S.K.; Vaughn, M.B.; Jessen, S.M.; Lawal, Y.; Gresk, C.J.; Yan, B.; Maziasz, T.J.; Cook, C.S.; Karim, A., 2001:
Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption

Noiri, E.; Ozawa, H.; Fujita, T.; Nakao, A., 2001:
Pharmacokinetics of cetirizine in chronic hemodialysis patients: multiple-dose study

Kidd, R.S.; Straughn, A.B.; Meyer, M.C.; Blaisdell, J.; Goldstein, J.A.; Dalton, J.T., 1999:
Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele

Sidell, N.; Sawatsri, S.; Connor, M.J.; Barua, A.B.; Olson, J.A.; Wada, R.K., 2000:
Pharmacokinetics of chronically administered all-trans-retinoyl-beta-glucuronide in mice

Wang-Mingxia; Ren-Leiming; Liang-Shangtian; Bai-Yiqing; Zhang-Jing; Bai-Yaling, 2000:
Pharmacokinetics of ciprofloxacin in patients with carcinoma of lungs

Morlet, N.; Graham, G.G.; Gatus, B.; McLachlan, A.J.; Salonikas, C.; Naidoo, D.; Goldberg, I.; Lam, C.M., 2000:
Pharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis

Cho, H.K.; Lush, R.M.; Bartlett, D.L.; Alexander, H.R.; Wu, P.C.; Libutti, S.K.; Lee, K.B.; Venzon, D.J.; Bauer, K.S.; Reed, E.; Figg, W.D., 1999:
Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis

Yu, B-Ning.; Chen, G-Lin.; He, N.; Ouyang, D-Sheng.; Chen, X-Ping.; Liu, Z-Qian.; Zhou, H-Hao., 2003:
Pharmacokinetics of citalopram in relation to genetic polymorphism of CYP2C19

Randinitis, E.J.; Brodfuehrer, J.I.; Eiseman, I.; Vassos, A.B., 2001:
Pharmacokinetics of clinafloxacin after single and multiple doses

Ala-Houhala, I.; Saha, H.; Liukko-Sipi, S.; Ylitalo, P.; Pasternack, A., 1999:
Pharmacokinetics of clodronate in haemodialysis patients

Zhou, M.; Song, Z.M.; Lidow, M.S., 2001:
Pharmacokinetics of cocaine in maternal and fetal rhesus monkeys at mid-gestation

Zhou S.Y.an; Mei Q.B.ng; Zhou Jin; Zhao D.H.a, 2000:
Pharmacokinetics of colon-specific delivery of dexamethasone prodrug

Hebert, M.F.; Wacher, V.J.; Roberts, J.P.; Benet, L.Z., 2003:
Pharmacokinetics of cyclosporine pre- and post-liver transplantation

Morikawa, N.; Mori, T.; Abe, T.; Kawashima, H.; Takeyama, M.; Hori, S., 2000:
Pharmacokinetics of cytosine arabinoside, methotrexate, nimustine and valproic acid in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy

Lengyel, J.; Bojti, E.; Bolehovszky, A.; Grézal, G.; Klebovich, I.; Magyar, K., 1998:
Pharmacokinetics of deramciclane in rabbits

Martinsson, L.; Yang, X.; Beck, O.; Wahlgren, N.Gunnar.; Eksborg, S., 2003:
Pharmacokinetics of dexamphetamine in acute stroke

Persiani, S.; D'Amato, M.; Makovec, F.; Tavares, I.A.; Bishai, P.M.; Rovati, L.C., 2002:
Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males

Venn, R.M.; Karol, M.D.; Grounds, R.M., 2002:
Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive caret

Marzo, A.; Dal Bo, L.; Verga, F.; Ceppi Monti, N.; Abbondati, G.; Tettamanti, R.A.; Crivelli, F.; Uhr, M.R.; Ismaili, S., 2000:
Pharmacokinetics of diclofenac after oral administration of its potassium salt in sachet and tablet formulations

Lill, J.S.; O'Sullivan, T.; Bauer, L.A.; Horn, J.R.; Carithers, R.; Strandness, D.E.; Lau, H.; Chan, K.; Thakker, K., 2000:
Pharmacokinetics of diclofenac sodium in chronic active hepatitis and alcoholic cirrhosis

Wang, Y.; Livingston, E.; Patil, S.; McKinney, R.E.; Bardeguez, A.D.; Gandia, J.; O'Sullivan, M.J.; Clax, P.; Huang, S.; Unadkat, J.D., 1999:
Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study

Bolla, S.; Boinpally, R.R.; Poondru, S.; Devaraj, R.; Jasti, B.R., 2002 :
Pharmacokinetics of diethylcarbamazine after single oral dose at two different times of day in human subjects

Ilondu, N.; Orisakwe, O.E.; Ofoefule, S.; Afonne, O.J.; Obi, E.; Chilaka, K.C.; Orish, C., 2000:
Pharmacokinetics of diethylcarbamazine: prediction by concentration in saliva

Huang, T.H.ng; Cheng, H.H.rng; Tsai, S.Y.ang; Chao, P.D.wn Lee; Kuo, S.C.u, 2001:
Pharmacokinetics of different formulations of 2-phenyl-4-quinolone in rabbit

Valoti, M.; Frosini, M.; Dragoni, S.; Fusi, F.; Sgaragli, G., 2003:
Pharmacokinetics of diphenhydramine in healthy volunteers with a dimenhydrinate 25 mg chewing gum formulation

Mazzei, T.; Surrenti, C.; Novelli, A.; Biagini, M.R.; Fallani, S.; Cassetta, M.I.; Conti, S.; Surrenti, E., 1999:
Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis

Huang Xia; Chen Jun; Rong Zheng Xing; Jiang Xin Guo; Jiang Chang Bin; Chen Hong Zhuan, 2002:
Pharmacokinetics of domestic and imported isosorbide mononitrate sustained-release capsule following a single and multiple dose in healthy volunteers

Upton, R.A.; Knutson, J.C.; Bishop, C.W.; LeVan, L.W., 2003:
Pharmacokinetics of doxercalciferol, a new vitamin D analogue that lowers parathyroid hormone

Swenson, C.E.; Bolcsak, L.E.; Batist, G.; Guthrie, T.H.; Tkaczuk, K.H.; Boxenbaum, H.; Welles, L.; Chow, S-Chung.; Bhamra, R.; Chaikin, P., 2003:
Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer

van Ruth, S.; van Tellingen, O.; Korse, C.M.; Verwaal, V.J.; Zoetmulder, F.A.N., 2003:
Pharmacokinetics of doxorubicin and cisplatin used in intraoperative hyperthermic intrathoracic chemotherapy after cytoreductive surgery for malignant pleural mesothelioma and pleural thymoma

Izzedine, H.; Aymard, G.; Launay-Vacher, V.; Hamani, A.; Deray, G., 2000:
Pharmacokinetics of efavirenz in a patient on maintenance haemodialysis

Liu, H.C.; Liu, T.J.; Yang, Y.Y.; Hou, Y.N., 2001:
Pharmacokinetics of enantiomers of trans-tramadol and its active metabolite, trans-O-demethyltramadol, in human subjects

Paret, G.; Eyal, O.; Mayan, H.; Ben-Abraham, R.; Vardi, A.; Manisterski, Y.; Barzilay, Z.; Ezra, D., 1999:
Pharmacokinetics of endobronchial tolazoline administration in dogs

Heikkinen, H.; Saraheimo, M.; Antila, S.; Ottoila, P.; Pentikainen, P.J., 2001:
Pharmacokinetics of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, in man: A study using a stable isotope technique

Ogiso, T.; Kasutani, M.; Tanaka, H.; Iwaki, M.; Tanino, T., 2001:
Pharmacokinetics of epinastine and a possible mechanism for double peaks in oral plasma concentration profiles

Butterworth, J.; James, R.L.; Lin, Y.; Prielipp, R.C.; Hudspeth, A.S., 1999:
Pharmacokinetics of epsilon-aminocaproic acid in patients undergoing aortocoronary bypass surgery

Majumdar, A.K.; Musson, D.G.; Birk, K.L.; Kitchen, C.J.; Holland, S.; McCrea, J.; Mistry, G.; Hesney, M.; Xi, L.; Li, S.X.; Haesen, R.; Blum, R.A.; Lins, R.L.; Greenberg, H.; Waldman, S.; Deutsch, P.; Rogers, J.D., 2002:
Pharmacokinetics of ertapenem in healthy young volunteers

Auclair, B.; Nix, D.E.; Adam, R.D.; James, G.T.; Peloquin, C.A., 2001:
Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacids

Wada, I.; Yokouchi, M.; Saitoh, H.; Takada, M.; Nakabayashi, T.; Mino, K.; Honma, T.; Takeda, T.; Hirano, K., 1999 :
Pharmacokinetics of etoposide after intrathoracic instillation to lung cancer patients with pleural effusion

Morikawa, N.; Mori, T.; Abe, T.; Kawashima, H.; Takeyama, M.; Hori, S., 1999:
Pharmacokinetics of etoposide and carboplatin in cerebrospinal fluid and plasma during hyperosmotic disruption of the blood brain barrier and intraarterial combination chemotherapy

Agrawal, N.G.B.; Rose, M.J.; Matthews, C.Z.; Woolf, E.J.; Porras, A.G.; Geer, L.A.; Larson, P.J.; Cote, J.; Dilzer, S.C.; Lasseter, K.C.; Alam, I.; Petty, K.J.; Gottesdiener, K.M., 2003:
Pharmacokinetics of etoricoxib in patients with hepatic impairment

Appel-Dingemanse, S.; Smith, T.; Merz, M., 2002:
Pharmacokinetics of fluvastatin in subjects with renal impairment and nephrotic syndrome

Lober, S.; Ziege, S.; Rau, M.; Schreiber, G.; Mignot, A.; Koeppe, P.; Lode, H., 1999:
Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium

Steinman, A.; Isoherranen, N.; Ashoach, O.; Soback, S., 2002:
Pharmacokinetics of gentamicin C1, C1a and C2 in horses after single intravenous dose

Courtois, P.; Sener, A.; Herbaut, C.; Turc, A.; Malaisse, W.J., 1999:
Pharmacokinetics of gliquidone, glibenclamide, gliclazide and glipizide in middle-aged and aged subjects

Wada, I.; Takeda, T.; Sato, M.; Saitoh, H.; Nakabayashi, T.; Mino, K.; Honma, T.; Takada, M.; Hirano, K., 2001:
Pharmacokinetics of granisetron in adults and children with malignant diseases

Bui, K.Q.; Ambrose, P.G.; Nicolau, D.P.; Lapin, C.D.; Nightingale, C.H.; Quintiliani, R., 2001:
Pharmacokinetics of high-dose meropenem in adult cystic fibrosis patients

Tóth, G.G.; Kloosterman, C.; Uges, D.R.; Jonkman, M.F., 1999:
Pharmacokinetics of high-dose oral and intravenous dexamethasone

Metz, C.; Göbel, L.; Gruber, M.; Hoerauf, K.H.; Taeger, K., 2000:
Pharmacokinetics of human cerebral opioid extraction: a comparative study on sufentanil, fentanyl, and alfentanil in a patient after severe head injury

de la Motte, S.; Klinger, J.; Kefer, G.; King, T.; Harrison, F., 2001:
Pharmacokinetics of human growth hormone administered subcutaneously with two different injection systems

Lehmann, G.; Asskali, F.; Foerster, H., 2003:
Pharmacokinetics of hydroxyethyl starch (70/0.5) following repeated infusions

Katano, K.; Tsujitani, S.; Oka, S.; Saito, H.; Gomyo, Y.; Kondo, A.; Ikeguchi, M.; Maeta, M.; Kaibara, N., 2000:
Pharmacokinetics of hypotonic cisplatin chemotherapy administered into the peritoneal and the pleural cavities in experimental model

Dong, J.Q.; Ni, L.; Scott, C.S.; Retsch-Bogart, G.Z.; Smith, P.C., 2000:
Pharmacokinetics of ibuprofen enantiomers in children with cystic fibrosis

Kuhlmann, O.; Hofmann, H-Stefan.; Müller, S.P.; Weiss, M., 2003:
Pharmacokinetics of idarubicin in the isolated perfused rat lung: effect of cinchonine and rutin

Comandone, A.; Leone, L.; Oliva, C.; Frustaci, S.; Monteleone, M.; Colussi, A.M.; Dal Canton, O.; Bergnolo, P.; Boglione, A.; Bumma, C., 1998:
Pharmacokinetics of ifosfamide administered according to three different schedules in metastatic soft tissue and bone sarcomas

Schrijvers, D.; Pronk, L.; Highley, M.; Bruno, R.; Locci-Tonelli, D.; D.B.uijn, E.; Van Oosterom, A.T.; Verweij, J., 2000:
Pharmacokinetics of ifosfamide are changed by combination with docetaxel: results of a phase I pharmacologic study

van Rossum, A.M.; de Groot, R.; Hartwig, N.G.; Weemaes, C.M.; Head, S.; Burger, D.M., 2000:
Pharmacokinetics of indinavir and low-dose ritonavir in children with HIV-1 infection

Hayashi, S.; Beckerman, K.; Homma, M.; Kosel, B.W.; Aweeka, F.T., 2000:
Pharmacokinetics of indinavir in HIV-positive pregnant women

Wissing, H.; Kuhn, I.; Rietbrock, S.; Fuhr, U., 2000:
Pharmacokinetics of inhaled anaesthetics in a clinical setting: comparison of desflurane, isoflurane and sevoflurane

Rietbrock, S.; Wissing, H.; Kuhn, I.; Fuhr, U., 2000:
Pharmacokinetics of inhaled anaesthetics in a clinical setting: description of a novel method based on routine monitoring data

Manley, H.J.; Bailie, G.R.; Frye, R.; Hess, L.D.; McGoldrick, M.D., 2000:
Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis

Shirbacheh, M.V.; Jones, J.W.; Harralson, T.A.; Edelstein, J.; Tecimer, T.; Breidenbach, W.C.; Jevans, A.W.; Maldonado, C.; Barker, J.H.; Gruber, S.A., 1999:
Pharmacokinetics of intra-arterial delivery of tacrolimus to vascularly isolated rabbit forelimb

Musson, D.G.; Majumdar, A.; Birk, K.; Holland, S.; Wickersham, P.; Li, S.X.; Mistry, G.; Fisher, A.; Waldman, S.; Greenberg, H.; Deutsch, P.; Rogers, J.Douglas., 2003:
Pharmacokinetics of intramuscularly administered ertapenem

Katano, K.; Tsujitani, S.; Maeta, M.; Fukuda, K.; Oka, S.; Hisamitsu, K.; Ikeguchi, M.; Kaibara, N., 2001:
Pharmacokinetics of intraoperative intrapleural cisplatin chemotherapy of various osmolarities in cases of esophageal cancer

Guan Liang; Zhang Ji, 2002:
Pharmacokinetics of intratumoral administration of biodegradable cisplatin polymer for treatment of C6 glioma in rats

Brown, S.D.; Bartlett, M.G.; White, C.A., 2003:
Pharmacokinetics of intravenous acyclovir, zidovudine, and acyclovir-zidovudine in pregnant rats

Cocquyt, V.; Kline, W.F.; Gertz, B.J.; Van Belle, S.J.; Holland, S.D.; DeSmet, M.; Quan, H.; Vyas, K.P.; Zhang, K.E.; D.G.ève, J.; Porras, A.G., 1999:
Pharmacokinetics of intravenous alendronate

Chiu, L.M.; Menhinick, A.M.; Johnson, P.W.; Amsden, G.W., 2002:
Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteers

Kim, Y.C.; Kim, Y.G.; Kim, E.J.; Cho, M.K.; Kim, S.G.; Lee, M.G., 2003:
Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes

Breilh, D.; Allaouchiche, B.; Jaumain, H.; Boulétreau, P.; Chassard, D.; Malbec, I.; Ducint, D.; Saux, M.C., 1999:
Pharmacokinetics of isepamicin during continuous venovenous hemodiafiltration

Lu, C-Cherng.; Ho, S-Tai.; Wong, C-Shung.; Wang, J-Joung.; Tsai, C-Song.; Hu, O.Yao-Pu.; Chang, S-Yran.; Lin, C-Yuan., 2003:
Pharmacokinetics of isoflurane: uptake in the body

Lu, C-Cherng.; Ho, S-Tai.; Wang, J-Joung.; Wong, C-Shung.; Hu, O.Yao-Pu.; Chang, S-Yran.; Lin, C-Yuan., 2003:
Pharmacokinetics of isoflurane: uptake in the brain

Nakamoto, T.; Inagawa, H.; Takagi, K.; Tashiro, K.; Yoshimura, H.; Nishizawa, T.; Honda, T.; Kanou, J.; Muto, Y.; Amm, E.; Soma, G., 2000:
Pharmacokinetics of isolated hepatic perfusion with high dose tumor necrosis factor in rat model

Schmitt, C.; Perel, Y.; Harousseau, J.L.; Lemerle, S.; Chwetzoff, E.; le Moing, J.P.; Levron, J.C., 2001:
Pharmacokinetics of itraconazole oral solution in neutropenic children during long-term prophylaxis

A.K.theeri, N.A.; Wasfi, I.A.; Lambert, M.; Saeed, A.; Khan, I.A., 2000:
Pharmacokinetics of ketoprofen enantiomers after intravenous administration of racemate in camels: effect of gender

Kokki, H.; L.L.boux, A.; Jekunen, A.; Montay, G.; Heikkinen, M., 2000:
Pharmacokinetics of ketoprofen syrup in small children

Yagi, N.; Taniuchi, Y.; Hamada, K.; Sudo, J-ichi.; Sekikawa, H., 2002:
Pharmacokinetics of ketotifen fumarate after intravenous, intranasal, oral and rectal administration in rabbits

Li, Y.C.; Guan, C.T.; Zhao, K.Q.; Chen, Z.L.; Li, T.L., 2001:
Pharmacokinetics of lactosaminated recombinant human growth hormone in mice

Atarashi, H.; Kuruma, A.; Yashima, M.; Saitoh, H.; Ino, T.; Endoh, Y.; Hayakawa, H., 2000:
Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias

Sjöquist, B.; Tajallaei, S.; Stjernschantz, J., 1999:
Pharmacokinetics of latanoprost in the cynomolgus monkey. 1st communication: single intravenous, oral or topical administration on the eye

Sjöquist, B.; Uhlin, A.; Byding, P.; Stjernschantz, J., 1999:
Pharmacokinetics of latanoprost in the cynomolgus monkey. 2nd communication: repeated topical administration on the eye

Sjoquist, B.; Johansson, A.; Stjernschantz, J., 1999:
Pharmacokinetics of latanoprost in the cynomolgus monkey. 3rd communication: Tissue distribution after topical administration on the eye studied by whole body autoradiography

Li, J.; Yao, H-Wei.; Jin, Y.; Zhang, Y-Fang.; Li, C-Yu.; Li, Y-Hai.; Xu, S-Yun., 2002:
Pharmacokinetics of leflunomide in Chinese healthy volunteers

Isoherranen, N.; Yagen, B.; Soback, S.; Roeder, M.; Schurig, V.; Bialer, M., 2001:
Pharmacokinetics of levetiracetam and its enantiomer (R)-alpha-ethyl-2-oxo-pyrrolidine acetamide in dogs

Malone, R.S.; Fish, D.N.; Abraham, E.; Teitelbaum, I., 2001:
Pharmacokinetics of levofloxacin and ciprofloxacin during continuous renal replacement therapy in critically ill patients

Kivikko, M.; Antila, S.; Eha, J.; Lehtonen, L.; Pentikäinen, P.J., 2002:
Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure

Brier, M.E.; Stalker, D.J.; Aronoff, G.R.; Batts, D.H.; Ryan, K.K.; O'Grady, M.; Hopkins, N.K.; Jungbluth, G.L., 2003:
Pharmacokinetics of linezolid in subjects with renal dysfunction

Hassan, Z.; Ljungman, P.; Ringdén, O.; Winiarski, J.; Nilsson, C.; Aschan, J.; Whitley, H.R.; Hassan, M., 2001:
Pharmacokinetics of liposomal busulphan in man

Arancibia, A.; Paulos, C.; Chávez, J.; Ritschel, W.A., 2003:
Pharmacokinetics of lithium in healthy volunteers after exposure to high altitude

Zhang, Y-Fan.; Chen, X-Yan.; Zhong, D-Fang.; Dong, Y-Mei., 2003:
Pharmacokinetics of loratadine and its active metabolite descarboethoxyloratadine in healthy Chinese subjects

Moon, C.H.; Lee, H.J.; Jung, Y.S.; Lee, S.H.; Baik, E.J., 1998:
Pharmacokinetics of losartan and its metabolite, EXP3174, after intravenous and oral administration of losartan to rats with streptozotocin-induced diabetes mellitus

Mascher, H.; Kikuta, C.; Schiel, H., 2001:
Pharmacokinetics of menthol and carvone after administration of an enteric coated formulation containing peppermint oil and caraway oil

van Enk, J.G.; Touw, D.J.; Lafeber, H.N., 2001:
Pharmacokinetics of meropenem in preterm neonates

Huang R.H.ng; Sun Wei Jian; Kong Fan Wen; Yang Wei Zhong; Luo Jie, 2001:
Pharmacokinetics of methotrexate in cerebrospinal fluid after intracerebroventricular chemotherapy to a patient with recurrent intracranial germioma

Kramer, R.E.; Wellman, S.E.; Rockhold, R.W.; Baker, R.C., 2002:
Pharmacokinetics of methyl parathion: a comparison following single intravenous, oral or dermal administration

Huang, J.; Chuang, S.K.; Cheng, C.L.; Lai, M.L., 1999:
Pharmacokinetics of metoprolol enantiomers in Chinese subjects of major CYP2D6 genotypes

Shih, P-Shan.; Huang, J-Ding., 2002:
Pharmacokinetics of midazolam and 1'-hydroxymidazolam in Chinese with different CYP3A5 genotypes

Mulla, H.; McCormack, P.; Lawson, G.; Firmin, R.K.; Upton, D.Robert., 2003:
Pharmacokinetics of midazolam in neonates undergoing extracorporeal membrane oxygenation

Sitsen, J.M.; Voortman, G.; Timmer, C.J., 2000:
Pharmacokinetics of mirtazapine and lithium in healthy male subjects

Otter, K.; Mignat, C.; Heber, D.; Ziegler, A., 2001:
Pharmacokinetics of morphine 3-esters after oral administration in rabbits

Prasad, P.P.; Yeh, C-Ming.; Gurrieri, P.; Glazer, R.; McLeod, J., 2002:
Pharmacokinetics of multiple doses of valsartan in patients with heart failure

Zhang, L.; Li, J-Tai.; Lu, Y.; Li, M-Ning.; Zhang, Y-Long.; Liu, Y.; Li, T-Yun.; Zhang, J-Wei., 2002:
Pharmacokinetics of multiple intravenous instillation of levofloxacin in Chinese healthy subjects

Neumann, I.; Haidinger, M.; Jäger, H.; Grützmacher, H.; Griesmacher, A.; Müller, M.M.; Bayer, P.M.; Meisl, F.Thomas., 2003:
Pharmacokinetics of mycophenolate mofetil in patients with autoimmune diseases compared renal transplant recipients

Jain, A.; Venkataramanan, R.; Hamad, I.S.; Zuckerman, S.; Zhang, S.; Lever, J.; Warty, V.S.; Fung, J.J., 2001:
Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus

Meier-Kriesche, H.U.; Shaw, L.M.; Korecka, M.; Kaplan, B., 2000:
Pharmacokinetics of mycophenolic acid in renal insufficiency

Lim, S.C.B.; Paech, M.J.; Sunderland, V.B.uce; Roberts, M.J.; Banks, S.L.; Rucklidge, M.W.M., 2003:
Pharmacokinetics of nasal fentanyl

Devineni, D.; Walter, Y.H.; Smith, H.T.; Lee, J.S.; Prasad, P.; McLeod, J.F., 2003:
Pharmacokinetics of nateglinide in renally impaired diabetic patients

Gotoh, A.; Hara, I.; Fujisawa, M.; Okada, H.; Arakawa, S.; Kudo, S.; Obe, T.; Maruyama, S.; Sakai, R.; Kamidono, S., 1999:
Pharmacokinetics of natural human IFN-alpha in hemodialysis patients

Kisor, D.F.; Plunkett, W.; Kurtzberg, J.; Mitchell, B.; Hodge, J.P.; Ernst, T.; Keating, M.J.; Gandhi, V., 2000:
Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies

Kosel, B.W.; Beckerman, K.P.; Hayashi, S.; Homma, M.; Aweeka, F.T., 2003:
Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women

Litalien, C.; Faye, A.; Compagnucci, A.; Giaquinto, C.; Harper, L.; Gibb, D.M.; Jacqz-Aigrain, E., 2003:
Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1

Taylor, S.; Little, J.; Halifax, K.; Drake, S.; Back, D., 2000:
Pharmacokinetics of nelfinavir and nevirapine in a patient with end-stage renal failure on continuous ambulatory peritoneal dialysis

Armbruster, C.; Vorbach, H.; E.M.nyawi, I.; Meisl, F.T.; Neumann, I., 2000:
Pharmacokinetics of nelfinavir during haemodialysis in a patient with HIV infection

Capparelli, E.V.; Sullivan, J.L.; Mofenson, L.; Smith, E.; Graham, B.; Britto, P.; Becker, M.I.; Holland, D.; Connor, J.D.; Luzuriaga, K., 2001:
Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants

Ericsson, H.; Tholander, B.; Björkman, J.A.; Nordlander, M.; Regårdh, C.G., 1999:
Pharmacokinetics of new calcium channel antagonist clevidipine in the rat, rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anesthetized dogs

Hérault, J.P.; Bernat, A.; Roye, F.; Michaux, C.; Schaeffer, P.; Bono, F.; Petitou, M.; Herbert, J.M., 2002:
Pharmacokinetics of new synthetic heparin mimetics

Rolf, C.; Gottschalk, I.; Behre, H.M.; Rauch, C.; Thyroff, U.; Nieschlag, E., 1999:
Pharmacokinetics of new testosterone transdermal therapeutic systems in gonadotropin-releasing hormone antagonist-suppressed normal men

Morikawa, N.; Mori, T.; Kawashima, H.; Takeyama, M.; Abe, T.; Kobayashi, H., 2001:
Pharmacokinetics of nimustine, cytosine arabinoside, and methotrexate in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy

Abrams, L., S.; Skee, D., M.; Natarajan, J.; Wong, F., A.; Leese, P., T.; Creasy, G., W.; Shangold, M., M., 2001:
Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho EvraTM/EvraTM) under conditions of heat, humidity, and exercise

Abrams, L.S.; Skee, D.M.; Wong, F.A.; Anderson, N.J.; Leese, P.T., 2001:
Pharmacokinetics of norelgestromin and ethinyl estradiol from two consecutive contraceptive patches

Brennscheidt, U.; Seiler, K.U.; Thomann, P., 2001:
Pharmacokinetics of nortilidine and naloxone after administration of tilidine/naloxone solution or tilidine/naloxone sustained release tablets

Heatherington, A.C.; Schuller, J.; Mercer, A.J., 2001:
Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: preliminary report

Macdougall, I.C.; Gray, S.J.; Elston, O.; Breen, C.; Jenkins, B.; Browne, J.; Egrie, J., 1999:
Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients

Gascón, A.R.; Campo, E.; Hernández, R.M.; Calvo, B.; Errasti, J.; Pedraz Muñoz, J.L., 2000:
Pharmacokinetics of ofloxacin enantiomers after intravenous administration for antibiotic prophylaxis in biliary surgery

Aliño, S.F.; Crespo, J.; Tarrasón, G.; Blaya, C.; Adán, J.; Escrig, E.; Benet, M.; Crespo, A.; Peris, J.E.; Piulats, J., 2000:
Pharmacokinetics of oligodeoxynucleotides encapsulated in liposomes: effect of lipid composition and preparation method

F.L.ang Qing; Huang Feng; W.D.Z.eng; Guo Jun Hua, 2003 :
Pharmacokinetics of omeprazole and its metabolites in Chinese healthy subjects

Low, C.L.; Gopalakrishna, K.; Lye, W.C., 2000:
Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients

Gosden, P.E.; Bedford, K.A.; Dixon, J.J.; Speidel, B.D.; Leaf, A.A.; Macgowan, A.P., 2001:
Pharmacokinetics of once-a-day netilmicin (4.5 mg/kg) in neonates

Cardiello, P.G.; Monhaphol, T.; Mahanontharit, A.; van Heeswijk, R.P.; Burger, D.; Hill, A.; Ruxrungtham, K.; Lange, J.M.; Cooper, D.A.; Phanuphak, P., 2003:
Pharmacokinetics of once-daily saquinavir hard-gelatin capsules and saquinavir soft-gelatin capsules boosted with ritonavir in HIV-1-infected subjects

Tod, M.; Lokiec, F.; Bidault, R.; D.B.ny, F.; Petitjean, O.; Aujard, Y., 2000:
Pharmacokinetics of oral acyclovir in neonates and in infants: a population analysis

Lal, J.; Kumar, V.; Gupta, R.C., 2003:
Pharmacokinetics of oral and transdermal administration of a sulphur mustard decontaminant CC-2(N,N'-dichlorobis(2,4,6-trichlorophenyl) urea) in rats: A preliminary study

Malingré, M.M.; Ten Bokkel Huinink, W.W.; Duchin, K.; Schellens, J.H.; Beijnen, J.H., 2001:
Pharmacokinetics of oral cyclosporin A when co-administered to enhance the oral absorption of paclitaxel

Zampino, M.G.; Colleoni, M.; Bajetta, E.; Stampino, C.G.; Guenzi, A.; de Braud, F., 1999:
Pharmacokinetics of oral doxifluridine in patients with colorectal cancer

Krueger, M.; Achenbach, H.; Terhaag, B.; Haase, H.; Richter, K.; Oertel, R.; Preiss, R., 2001:
Pharmacokinetics of oral talinolol following a single dose and during steady state in patients with chronic renal failure and healthy volunteers

Callender, D.P.; Jayaprakash, N.; Bell, A.; Petraitis, V.; Petraitiene, R.; Candelario, M.; Schaufele, R.; Dunn, J.M.; Sei, S.; Walsh, T.J.; Balis, F.M.; Petratienes, R., 1999:
Pharmacokinetics of oral zidovudine entrapped in biodegradable nanospheres in rabbits

Bergeron, R.J.; Weimar, W.R.; Wiegand, J., 1999:
Pharmacokinetics of orally administered desferrithiocin analogs in cebus apella primates

Liu-Changxiao; Gu-Yibao; Li-Quansheng, 1999:
Pharmacokinetics of oxiracetam in rats and mice

Tomita, M.; Kurata, H.; Aoki, Y.; Tanaka, K.; Kazama, J.J., 2001:
Pharmacokinetics of paclitaxel and cisplatin in a hemodialysis patient with recurrent ovarian cancer

Kimura, T.; Kokubun, H.; Shimada, S.; Nishisako, M.; Nowatari, M.; Oguchi, K.; Matsuura, N.; Nonoyama, M.; Sunakawa, K., 2000:
Pharmacokinetics of panipenem in neonates and dosage recommendation

Chaudhary, R.K.; Srivastava, A.K., 1999:
Pharmacokinetics of paracetamol administered with cefuroxime in crossbred calves

Sharma, S.K.; Srivastava, A.K., 2000:
Pharmacokinetics of paracetamol when administered with cefotaxime in crossbred calves

Srinivasu, P.; Rambhau, D.; Rao, B.R.; Rao, Y.M., 1999:
Pharmacokinetics of pentoxifylline after oral administration of a sustained release tablet at two different times of the day

Chow, H-H.Sherry.; Salazar, D.; Hakim, I.A., 2002:
Pharmacokinetics of perillic acid in humans after a single dose administration of a citrus preparation rich in d-limonene content

Mohammed Ebid, A.H.; Abdel-Rahman, H.M., 2001:
Pharmacokinetics of phenobarbital during certain enhanced elimination modalities to evaluate their clinical efficacy in management of drug overdose

Tulunay, F.C.; Onaran, H.O.; Ergün, H.; Ucar, A.; Usanmaz, S.; Embil, K.; Tulunay, M., 1998:
Pharmacokinetics of phenprobamate after oral administration to healthy subjects

Badyal, D.K.; Garg, S.K., 2000:
Pharmacokinetics of phenytoin: Unaltered by ciprofloxacin in rhesus monkeys

Leusch, A.; Eichhorn, B.; Busch, U.; Ensinger, H.A., 2002:
Pharmacokinetics of pinokalant, a new nonselective cation channel blocker in the rat

Potgieter, G.E.; Groenewoud, G.; Jordaan, P.J.; Hundt, H.K.L.; Schall, R.; Kummer, M.; Sewarte-Ross, Günter., 2002:
Pharmacokinetics of pipamperone from three different tablet formulations

Mueller, S.C.; Majcher-Peszynska, J.; Hickstein, H.; Francke, A.; Pertschy, A.; Schulz, M.; Mundkowski, R.; Drewelow, B., 2002:
Pharmacokinetics of piperacillin-tazobactam in anuric intensive care patients during continuous venovenous hemodialysis

Zhang, X.; Nieforth, K.; Lang, J-Marie.; Rouzier-Panis, R.; Reynes, J.; Dorr, A.; Kolis, S.; Stiles, M.R.; Kinchelow, T.; Patel, I.H., 2002:
Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: Inverse Gaussian density absorption and 2-compartment disposition

Park, J.W.; Siekmeier, R.; Merz, M.; Krell, B.; Harder, S.; März, W.; Seidel, D.; Schüler, S.; Gross, W., 2002:
Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A

van der Meer, A.D.; Burm, A.G.; Stienstra, R.; van Kleef, J.W.; Vletter, A.A.; Olieman, W., 1999:
Pharmacokinetics of prilocaine after intravenous administration in volunteers: enantioselectivity

Mircioiu, C.; Perju, A.; Neagu, A.; Griu, E.; Calin, G.; Miron, D.S., 1998:
Pharmacokinetics of progesterone in postmenopausal women: 1. Pharmacokinetics following intravaginal administration

Pace, S.; Longo, A.; Toon, S.; Rolan, P.; Evans, A.M., 2000:
Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption

Servin, Fédérique.S.; Bougeois, B.; Gomeni, R.; Mentré, F.; Farinotti, R.; Desmonts, J-Marie., 2003:
Pharmacokinetics of propofol administered by target-controlled infusion to alcoholic patients

Morikawa, N.; Oishi, K.; Takeyama, M.; Noguchi, T., 2002:
Pharmacokinetics of propofol in elderly coronary artery bypass graft patients under total intravenous anesthesia

Rigby-Jones, A.E.; Nolan, J.A.; Priston, M.J.; Wright, P.M.C.; Sneyd, J.Robert.; Wolf, A.R., 2002:
Pharmacokinetics of propofol infusions in critically ill neonates, infants, and children in an intensive care unit

Cawello, W.; Samadi, N.; Schweer, H.; Wilberz, S.; Kuhlmann, U.; Lange, H.; Seyberth, H.W., 1999:
Pharmacokinetics of prostaglandin E1 in patients undergoing haemodialysis

L.N.; L.M.i; Chen Hui; Meng D.P.ng; Chen Yuan Hua, 2002:
Pharmacokinetics of puerarin in patients with diabetic nephropathy

Blumer, J.L.; Daniels, S.R.; Dreyer, W.J.; Batisky, D.; Walson, P.D.; Roman, D.; Ouellet, D., 2003:
Pharmacokinetics of quinapril in children: assessment during substitution for chronic angiotensin-converting enzyme inhibitor treatment

Turyn, D.; D.S.lva, R.S.; Marques, M., 2000:
Pharmacokinetics of radioiodinated growth hormones in the turtle Chrysemys dorbigni

Reynolds, L.M.; Infosino, A.; Brown, R.; Hsu, J.; Fisher, D.M., 2000:
Pharmacokinetics of rapacuronium in infants and children with intravenous and intramuscular administration

Poggesi, I.; Pellizzoni, C.; Fleishaker, J.C., 2000:
Pharmacokinetics of reboxetine in elderly patients with depressive disorders

Hendershot, P.E.; Fleishaker, J.C.; Lin, K.M.; Nuccio, I.D.; Poland, R.E., 2001:
Pharmacokinetics of reboxetine in healthy volunteers with different ethnic descents

McCarthy, K.; Stewart, P.; Sigman, J.; Read, M.; Keith, J.C.; Brinkhous, K.M.; Nichols, T.C.; Schaub, R.G., 2002:
Pharmacokinetics of recombinant factor IX after intravenous and subcutaneous administration in dogs and cynomolgus monkeys

Lee, C.A.; Owens, D.; Bray, G.; Giangrande, P.; Collins, P.; Hay, C.; Gomperts, E.; Schroth, P.; Barrowcliffe, T., 1999:
Pharmacokinetics of recombinant factor VIII (recombinate) using one-stage clotting and chromogenic factor VIII assay

Liu Xiu Wen; Tang Zhong Ming; Song Hai Feng; Zhu Bao Zhen; Wang L.P.ng; Zhang Yang, 2002:
Pharmacokinetics of recombinant human basic fibroblast growth factor following intravenous bolus plus infusion in rhesus monkey

Zhu-Zhenfeng; Liu-Fengzhi; Yang-Qinyu; Ma-Tongxun; Xiong-Shisong; Zhao-Min; Liu-Xin, 1999:
Pharmacokinetics of recombinant human interferon alpha-2a in healthy volunteers

Jiang Chun Lei; L.Z.en; G.C.ang Hong; H.C.eng; Huang A.J.n; Yuan B.J.n; L.C.ang Lin, 2001:
Pharmacokinetics of recombinant modified human tumor necrosis factor mutant in mice

Lu, W.; Mant, T.; Levy, J.H.; Bailey, J.M., 2000 :
Pharmacokinetics of recombinant transgenic antithrombin in volunteers

Hahn, T.W.; Henneberg, S.W.; Holm-Knudsen, R.J.; Eriksen, K.; Rasmussen, S.N.; Rasmussen, M., 2000:
Pharmacokinetics of rectal paracetamol after repeated dosing in children

Ross, A.K.; Davis, P.J.; Dear Gd, G.L.; Ginsberg, B.; McGowan, F.X.; Stiller, R.D.; Henson, L.G.; Huffman, C.; Muir, K.T., 2001:
Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures

Peloquin, C.A.; Namdar, R.; Singleton, M.D.; Nix, D.E., 1999:
Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids

Keung, A.C.; Owens, R.C.; Eller, M.G.; Weir, S.J.; Nicolau, D.P.; Nightingale, C.H., 1999:
Pharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: a phase I study

Shelton, M.J.; Hewitt, R.G.; Adams, J.; Della-Coletta, A.; Cox, S.; Morse, G.D., 2003:
Pharmacokinetics of ritonavir and delavirdine in human immunodeficiency virus-infected patients

Izzedine, H.; Launay-Vacher, V.; Deray, G., 2001:
Pharmacokinetics of ritonavir and nevirapine in peritoneal dialysis

Musson, D.G.; Birk, K.L.; Panebianco, D.L.; Gagliano, K.D.; Rogers, J.D.; Goldberg, M.R., 2001:
Pharmacokinetics of rizatriptan in healthy elderly subjects

Pere, P.; Salonen, M.; Jokinen, M.; Rosenberg, P.H.; Neuvonen, P.J.; Haasio, J., 2003:
Pharmacokinetics of ropivacaine in uremic and nonuremic patients after axillary brachial plexus block

Thompson-Culkin, K.; Zussman, B.; Miller, A.K.; Freed, M.I., 2002 :
Pharmacokinetics of rosiglitazone in patients with end-stage renal disease

Chapelsky, M.C.; Thompson-Culkin, K.; Miller, A.K.; Sack, M.; Blum, R.; Freed, M.I., 2003:
Pharmacokinetics of rosiglitazone in patients with varying degrees of renal insufficiency

Oliyai, R.; Arimilli, M.N.; Jones, R.J.; Lee, W.A., 2001:
Pharmacokinetics of salicylate ester prodrugs of cyclic HPMPC in dogs

Boffito, M.; Carriero, P.; Trentini, L.; Raiteri, R.; Bonora, S.; Sinicco, A.; Reynolds, H.E.; Hoggard, P.G.; Back, D.J.; D.P.rri, G., 2002:
Pharmacokinetics of saquinavir co-administered with cimetidine

Vouillamoz-Lorenz, S.; Buclin, T.; Lejeune, F.; Bauer, J.; Leyvraz, S.; Decosterd, L.Arthur., 2003:
Pharmacokinetics of satraplatin (JM216), an oral platinum (IV) complex under daily oral administration for 5 or 14 days

Liu, S.L.ng; Hsieh, M.T.uen; Liu, C.H.iung, 1999:
Pharmacokinetics of scopoletin after intravenous administration in rabbits

Nichols, D., J.; Muirhead, G., J.; Harness, J., A., 2002:
Pharmacokinetics of sildenafil citrate after single oral doses in healthy male subjects: Absolute bioavailability, food effects and dose proportionality

Grasela, D.M.; Stoltz, R.R.; Barry, M.; Bone, M.; Mangold, B.; O'Grady, P.; Raymond, R.; Haworth, S.J., 2000:
Pharmacokinetics of single-dose oral stavudine in subjects with renal impairment and in subjects requiring hemodialysis

Coulomb, F.; Ducret, F.; Laneury, J.P.; Fiorentini, F.; Poggesi, I.; Jannuzzo, M.G.; Fleishaker, J.C.; Houin, G.; Duchêne, P., 2000:
Pharmacokinetics of single-dose reboxetine in volunteers with renal insufficiency

Kohn, M.C.; Melnick, R.L.; Ye, F.; Portier, C.J., 2002:
Pharmacokinetics of sodium nitrite-induced methemoglobinemia in the rat

L.L.mer, S.; Poucheret, P.; Cros, G.; de Richter, R.K.; Bonnet, P.A.; Bressolle, F., 2000:
Pharmacokinetics of sodium tungstate in rat and dog: a population approach

Rongkavilit, C.; Thaithumyanon, P.; Chuenyam, T.; Damle, B.D.; Limpongsanurak, S.; Boonrod, C.; Srigritsanapol, A.; Hassink, E.A.; Hoetelmans, R.M.; Cooper, D.A.; Lange, J.M.; Ruxrungtham, K.; Phanuphak, P., 2001:
Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates

Jain, S.K.; Punia, J.S., 2000:
Pharmacokinetics of sulfadoxine following intravenous administration in white leg horn (WLH) chicken

Christensen, M.L.; Mottern, R.K.; Jabbour, J.T.; Fuseau, E., 2003:
Pharmacokinetics of sumatriptan nasal spray in adolescents

Zheng Ping; H.M.ng Yan; Luo Qin; Yang Ling, 2001:
Pharmacokinetics of tacrolimus in nine kidney transplant patients

Xu-Xin-Jun; Liu-Gao-Lin; Deng-Yu-Lin; Miao-Hai-Jun; Qian-Fang; Zhang-Zheng-Xing; An-Deng-Kui, 2002:
Pharmacokinetics of tacrolimus, a novel potent immunosuppressant in healthy Chinese volunteers

Undre, N.A., 2003:
Pharmacokinetics of tacrolimus-based combination therapies

Izzedine, H.; Launay-Vacher, V.; Jullien, V.; Aymard, G.; Duvivier, C.; Deray, G., 2003:
Pharmacokinetics of tenofovir in haemodialysis

Leusch, A.; Tröger, W.; Greischel, A.; Roth, W., 2000:
Pharmacokinetics of the M1-agonist talsaclidine in mouse, rat, rabbit and monkey, and extrapolation to man

Murayama, N.; McMahon, H.; Young, C.G.; McCracken, N.W.; Okamura, Y.; Hakusui, H.; Tanaka, M., 2000:
Pharmacokinetics of the anticoagulant 14C-DX-9065a in the healthy male volunteer after a single intravenous dose

Ma, L.; Hurwitz, S.J.; Shi, J.; Mcatee, J.J.; Liotta, D.C.; McClure, H.M.; Schinazi, R.F., 1999:
Pharmacokinetics of the antiviral agent beta-D-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine in rhesus monkeys

Fekkes, D.; Tuiten, A.; Bom, I.; Pepplinkhuizen, L., 2001:
Pharmacokinetics of the beta-carboline norharman in man

Lippi, A.; Criscuoli, M.; Guelfi, M.; Santicioli, P.; Maggi, C.A., 1998:
Pharmacokinetics of the bicyclic peptide tachykinin NK2 receptor antagonist MEN 11420 (nepadutant) in rats

Dal-Negro, R.W.; Tognella, S.; Micheletto, C., 2002:
Pharmacokinetics of the effect of nebivolol 5mg on airway patency in patients with mild to moderate bronchial asthma and arterial hypertension: A randomised, placebo-controlled study

Namour, F.; Wessels, D.H.; Pascual, M.H.; Reynolds, D.; Sultan, E.; Lenfant, B., 2000:
Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses

Hussein, Z.; Beerahee, M.; Grover, R.; Jordan, B.; Jeffs, R.; Donaldson, J.; Zaccardelli, D.; Colice, G.; Guntupalli, K.; Watson, D.; Vincent, J.L.uis, 1999:
Pharmacokinetics of the nitric oxide synthase inhibitor L-NG-methylarginine hydrochloride in patients with septic shock

Prats, P.A.; Alvarez, D.; Torrens, I.; Hayes, O.; Zayas, F.; Rodriguez, I.; Duconge, J.; Fernandez Sanchez, E., 2002:
Pharmacokinetics of the novel recombinant streptokinase 125I-mut-C42

Austin, N.E.; Baldwin, S.J.; Cutler, L.; Deeks, N.; Kelly, P.J.; Nash, M.; Shardlow, C.E.; Stemp, G.; Thewlis, K.; Ayrton, A.; Jeffrey, P., 2001:
Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase

Burger, D.M.; van Rossum, A.M.; Hugen, P.W.; Suur, M.H.; Hartwig, N.G.; Geelen, S.P.; Scherpbier, H.J.; Hoetelmans, R.M.; Vulto, A.G.; de Groot, R., 2001:
Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children

Plum, A.; Agerso, H.; Andersen, L., 2000:
Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, in rats, dogs, and pigs, and pharmacodynamics of insulin aspart in pigs

Bading, J., R.; Shahinian, A., H.; Bathija, P.; Conti, P., S., 2000:
Pharmacokinetics of the thymidine analog 2'-fluoro-5-(14C)-methyl-1-beta-D-arabinofuranosyluracil ((14C)FMAU) in rat prostate tumor cells


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close